Forza Innovations

FORZ

Medical - Devices · Healthcare

Price

$0.00

+0.00 (+0.00%)

Market Cap

$252,183

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+331.4% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 178.7M (2019) → 770.9M (2023)

Forza Innovations Inc. (FORZ) does not appear in my training data as a recognized public company. The ticker, name, and financial profile provided do not match any company I can reliably identify. Writing a factual description using invented product details or business model assumptions would risk misleading investors.

To generate an accurate description, please provide any of the following:

- **A brief business description** (even one sentence from a filing or website) - **Core products or services** the company sells - **Main customers or end markets** it serves - **Geographic footprint** (U.S. only, global, etc.)

Alternatively, if this is a very small or recently listed company, pulling the business description directly from its **SEC 10-K filing** (Item 1) would give the most reliable source material to work from.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-45.7% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-27.3% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

6.5%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~0 months

$0 cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Cash watch

Forza Innovations has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

97.6%

Premium pricing power — 97.6% gross margin

Operating Margin

2254.4%

Excellent — 2254.4% operating margin

ROCE

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+8.7%

Steady sales growth (8.7% YoY)

EPS YoY

N/A

—

Data not available

EPS Consistency

2/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

-88319.0%

Burning cash (-88319.0%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

—

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial